Welcome to our dedicated page for Iiot-Oxys SEC filings (Ticker: ITOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IIOT-OXYS, Inc. filings document the reporting obligations, capital structure, and material events of a Nevada technology company quoted under ITOX. The filing record includes Forms 8-K for securities purchase agreements, amendments to preferred-stock designations, promissory note extensions, and debt-exchange matters.
Company disclosures also cover Series D Convertible Preferred Stock, Series A Super-voting Preferred Stock, relationships with financing counterparties, and notifications of late Form 10-K or Form 10-Q filings tied to the completion of auditor review processes. These records provide formal detail on governance actions, financing instruments, and periodic-reporting status.
IIOT-OXYS, Inc. director Mark Grober files an initial ownership report showing indirect holdings in the company through GHS Investments LLC. The filing lists 1,250,000 shares of common stock held indirectly, along with several convertible and preferred securities that can turn into additional common shares.
The indirect holdings include a convertible note tied to 23,158,450 shares of common stock, 10,000 shares of Series A Preferred Stock, 1,166,000,000 shares of Series B Preferred Stock, and 525,000,000 shares of Series D Preferred Stock. Many of these instruments are subject to a 4.99% beneficial ownership limitation and specified conversion formulas and pricing terms. The filing also notes that Grober became a director of IIOT-OXYS effective November 5, 2025, and that he disclaims beneficial ownership beyond his economic interest in GHS Investments LLC.
IIOT-OXYS, Inc. director Sarfraz Hajee filed an initial ownership report showing that GHS Investments LLC, an entity of which he is a member, holds various securities of the company. The filing reports indirect beneficial ownership through the LLC, with a disclaimer limiting his beneficial interest to his pecuniary stake.
The LLC holds 1,250,000 shares of Common Stock, a convertible note for 23,158,450 underlying common shares, and preferred stock series that are convertible into common stock, including Series A, B, and D Preferred Stock. These derivative holdings are subject to a 4.99% beneficial ownership limitation and remain convertible while outstanding.
The filing also notes that Hajee became a director effective November 5, 2025, and that the convertible note and preferred shares carry conversion mechanics tied to the company’s market trading prices over specified look-back periods.
IIOT-OXYS, Inc. continues to face significant financial strain as of September 30, 2025. The company reported no revenue for the quarter or the first nine months of 2025, compared with $2,500 of revenue in the same nine-month period of 2024. Net loss attributable to common stockholders was $408,889 for the quarter and $669,613 year-to-date, and the company has an accumulated deficit of $11,877,865.
Liquidity is very tight: cash and cash equivalents were only $278, while current liabilities totaled $3,190,356, resulting in a working capital deficit of about $3.19 million and a stockholders’ deficit of $4,015,852. Management discloses that these losses, the cash used in operations, and the deficit raise substantial doubt about the company’s ability to continue as a going concern.
The company is funding itself through high-cost instruments, including Series B, C and D convertible preferred stock with embedded derivatives and convertible notes totaling $393,942 of principal, all classified as current. For the nine months, operating cash outflow was $159,135, partly offset by $141,000 raised from preferred stock sales. A large overhang of potentially issuable shares from convertible securities adds significant dilution risk for common stockholders.
IIOT-OXYS, Inc. reported that on December 1, 2025 it amended its existing Securities Purchase Agreement with GHS Investments LLC for up to $210,000 of financing. Through Amendment No. 2, the company increased the maximum number of shares of its Series D Convertible Preferred Stock that may be issued to up to 259 shares and added a fifth additional closing. This new closing allows the sale of up to 34 shares of Series D Preferred Stock for a purchase price of up to $34,000, providing an additional small tranche of preferred equity capital under the agreement.
IIOT-OXYS, Inc. filed a Form 12b-25 (NT 10-Q) to notify a late filing for the quarter ended September 30, 2025. The company states it was unable to complete the review process with its auditor in time.
The notice references Rule 12b-25, which permits a brief extension for quarterly reports when timely filing would require unreasonable effort or expense. The notification was signed by CEO Clifford L. Emmons.
IIOT-OXYS reported a change in control and multiple debt-for-equity exchanges. The company issued 100 shares of Series A super-voting preferred stock to GHS Investments, giving GHS voting control. Concurrently, previously issued Series A preferred shares were terminated and the board was expanded to four members, with three GHS-affiliated directors appointed.
The company exchanged obligations into Series E preferred stock: $387,242 to its CEO for 268.529 Series E shares, $216,156 to a former director for 180 Series E shares, $323,269 to its former CFO for 269 Series E shares, and $522,195 to senior secured holders for 489 Series E shares, cancelling the related secured notes and security agreements. Two consultants agreed to exchange an aggregate of $9,985 of fees for 19,969,770 common shares. The CFO and a director resigned at closing, and consulting agreements were put in place. An asset transfer arrangement with Aingura IIoT includes escrowed Series E shares tied to a $30,843 fee.
IIOT-OXYS, Inc. (ITOX) reported several capital structure updates. The company extended the maturity of its $75,000 Convertible Promissory Note with GHS Investments from October 29, 2025 to April 29, 2026, and GHS waived all prior events of default.
The company amended its March 21, 2025 Securities Purchase Agreement with GHS, increasing the aggregate number of Series D Convertible Preferred shares issuable to 225, and raising the fourth additional closing to up to 35 shares for a purchase price of up to $35,000. IIOT-OXYS also designated a new class of Series E Convertible Preferred consisting of 3,000 shares.
For the Series E preferred, the company may redeem all outstanding shares on three business days’ notice at a price equal to 1.10 times the sum of the stated value, accrued but unpaid dividends, and other amounts due.
IIOT-OXYS, Inc. (ITOX) 10-Q snapshot: The company reported a net loss of $230,724 for the six months ended June 30, 2025 and used $112,726 in operating cash during that period. Management notes an accumulated deficit of $11,438,976 and explicitly states these factors raise substantial doubt about the company’s ability to continue as a going concern. The company remains largely pre-revenue historically, with nominal revenues since 2021.
The balance sheet shows extensive equity and preferred-stock activity: 566,315,293 common shares outstanding at June 30, 2025, multiple series of convertible preferred shares with stated liquidation preferences (Series B approx. $699,600; Series C $68,400; Series D $169,200), and material derivative and mezzanine liabilities related to convertible instruments (derivative liabilities reported at approximately $697,935 at June 30, 2025). Convertible notes and related-party notes carry 12% interest and are secured by substantially all company assets with maturities in early 2026.
IIOT-OXYS, Inc. (ITOX) 10-Q snapshot: The company reported a net loss of $230,724 for the six months ended June 30, 2025 and used $112,726 in operating cash during that period. Management notes an accumulated deficit of $11,438,976 and explicitly states these factors raise substantial doubt about the company’s ability to continue as a going concern. The company remains largely pre-revenue historically, with nominal revenues since 2021.
The balance sheet shows extensive equity and preferred-stock activity: 566,315,293 common shares outstanding at June 30, 2025, multiple series of convertible preferred shares with stated liquidation preferences (Series B approx. $699,600; Series C $68,400; Series D $169,200), and material derivative and mezzanine liabilities related to convertible instruments (derivative liabilities reported at approximately $697,935 at June 30, 2025). Convertible notes and related-party notes carry 12% interest and are secured by substantially all company assets with maturities in early 2026.